MolecularMD is proving that it is possible to devise and commercialize a functioning and useful companion diagnostic. Hear Dan Synder, President and COO, talk about how to make this possible and what you can do to drive your own business forward in Health Care Insight’s Overcoming Companion Diagnostics Challenges podcast.
Companion diagnostics are critical to the success of personalized medicine. They are tests designed to support treatment decisions based on the efficacy and safety of a specific therapeutic treatment in a defined patient population.
The podcast covers how to:
? Overcome Challenges
Learn from the greatest challenges facing the companion diagnostics field today and unconventional methods to overcome them, including the utilization of novel assay platforms
? Manage Stakeholder Relationships
Hear best practices on how to break down silos between stakeholders so all parties communicate effectively and are satisfied in the development of companion diagnostics
? Structure Simultaneous Development
Learn how to synchronize the simultaneous development and approval of drug and diagnostic
? Develop Key Partnerships
Partnerships between pharma and diagnostics companies are essential. Gain insights on how best to share risk and reward and learn what are critical “go / no-go” project points